Neuropsychiatric and cognitive symptoms across the Alzheimer's disease clinical spectrum: Cross-sectional and longitudinal associations
By
Willem S Eikelboom,
Esther van den Berg,
Ellen Singleton,
Sara J. Baart,
Michiel Coesmans,
Annebet E. Leeuwis,
Charlotte E. Teunissen,
Bart N.M. van Berckel,
Yolande A.L. Pijnenburg,
Philip Scheltens,
Wiesje M. van der Flier,
Rik Ossenkoppele,
Janne M. Papma
Posted 20 Feb 2021
medRxiv DOI: 10.1101/2021.02.18.21251064
ObjectiveTo investigate the prevalence and trajectories of neuropsychiatric symptoms (NPS) in relation to cognitive functioning in a cohort of amyloid-{beta} positive individuals across the Alzheimers disease (AD) clinical spectrum. MethodsWe included 1,524 amyloid-{beta} positive individuals from the Amsterdam Dementia Cohort with subjective cognitive decline (SCD, n=113), mild cognitive impairment (MCI, n=321), or dementia (n=1,090). We measured NPS with the neuropsychiatric inventory (NPI), examining total scores and the presence of specific NPI-items. Cognition was assessed across five cognitive domains and with the MMSE. We examined trajectories including model based trends for NPS and cognitive functioning over time. We used linear mixed models to relate baseline NPI scores to cognitive functioning at baseline (whole-sample) and longitudinal time-points (subsample n=520, Mean=1.8 [SD=0.7] years follow-up). ResultsNPS were prevalent across all clinical AD stages (NPI total score [≥]1 81.4% in SCD, 81.2% in MCI, 88.7% in dementia). Cognitive functioning showed an uniform gradual decline; while in contrast, large intra-individual heterogeneity of NPS was observed over time across all groups. At baseline, we found associations between NPS and cognition in dementia that were most pronounced for NPI total scores and MMSE (range {beta}:-0.18-0.11, FDR-adjusted p<0.05), while there were no cross-sectional relationships in SCD and MCI ({beta}:-0.32- 0.36, FDR-adjusted p>0.05). There were no associations between baseline NPS and cognitive functioning over time in any clinical stage ({beta}:-0.13-0.44, FDR-adjusted p>0.05). ConclusionNPS and cognitive symptoms are both prevalent across the AD continuum, but show a different evolution during the course of the disease.
Download data
- Downloaded 413 times
- Download rankings, all-time:
- Site-wide: 107,014
- In neurology: 420
- Year to date:
- Site-wide: 67,997
- Since beginning of last month:
- Site-wide: 41,547
Altmetric data
Downloads over time
Distribution of downloads per paper, site-wide
PanLingua
News
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!